Viromed Co., Ltd.
Records under this name other than the patents Viromed Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,812,146 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,389,492 | Lyophilized DNA formulations for enhanced expression of plasmid DNA Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,168,859 | Ubiquitin regulatory elements Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,963,493 | Gene Therapy for Diabetic Neuropathy Using an HGF Isoform Formerly held In force · High confidence | In force | High confidence | |
| US 10,759,841 | Gene Therapy for Diabetic Neuropathy Using an HGF Isoform Formerly held In force · High confidence | In force | High confidence | |
| US 10,639,351 | Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,927,177 | Methods of treatment using anti-c-met antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,279,769 | Anti-Sialyl TN Chimeric Antigen Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 9,131,722 | Composition comprising the extract of Actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease Term ended Term ended Aug 12, 2026 · From the USPTO record | Term ended | Term ended Aug 12, 2026 | From the USPTO record |
| US 8,716,446 | Biopolymer conjugates comprising an interleukin-11 analog Lapsed on the fee record Ended May 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2026 | From the USPTO record |